Xing Ji

459 total citations
24 papers, 200 citations indexed

About

Xing Ji is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xing Ji has authored 24 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xing Ji's work include RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Xing Ji is often cited by papers focused on RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Xing Ji collaborates with scholars based in China, United States and Germany. Xing Ji's co-authors include Cheng Fan, Weimin Yu, Yunlong Zhang, Yuqi Xia, Kang Chen, Ting Rao, Fangyou Lin, Xiangjun Zhou, Haohuan Li and Cong Liu and has published in prestigious journals such as Medicine, The Analyst and Cell Death and Disease.

In The Last Decade

Xing Ji

22 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Ji China 8 93 73 57 28 18 24 200
Jiahua Zou China 9 137 1.5× 77 1.1× 29 0.5× 20 0.7× 30 1.7× 19 278
Emily Watts United Kingdom 5 81 0.9× 33 0.5× 74 1.3× 20 0.7× 66 3.7× 8 242
Quan Liu China 9 84 0.9× 27 0.4× 22 0.4× 63 2.3× 17 0.9× 45 260
Songren Shu China 10 100 1.1× 34 0.5× 46 0.8× 42 1.5× 28 1.6× 23 265
Xinran Zhao China 9 154 1.7× 25 0.3× 121 2.1× 20 0.7× 28 1.6× 31 331
Qinhan Li China 7 183 2.0× 53 0.7× 63 1.1× 38 1.4× 26 1.4× 13 303
Samia Asif United States 7 63 0.7× 50 0.7× 25 0.4× 23 0.8× 11 0.6× 28 297
Shozaburo Doi Japan 7 70 0.8× 74 1.0× 21 0.4× 28 1.0× 17 0.9× 14 176
Pierre Laurin Canada 7 54 0.6× 97 1.3× 13 0.2× 26 0.9× 13 0.7× 21 222

Countries citing papers authored by Xing Ji

Since Specialization
Citations

This map shows the geographic impact of Xing Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Ji more than expected).

Fields of papers citing papers by Xing Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Ji. The network helps show where Xing Ji may publish in the future.

Co-authorship network of co-authors of Xing Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Ji. A scholar is included among the top collaborators of Xing Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Ji. Xing Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Liang, Qiuping Zhang, Zhigang Tang, et al.. (2025). Gut Microbiota–Derived Tryptophan Indole Metabolites Ameliorate Collagen‐Induced Arthritis in Mice Via Aryl Hydrocarbon Receptor Activation. Arthritis & Rheumatology. 78(3). 613–629.
3.
Ji, Xing, Xinzhu Liu, Xiaohui Jin, et al.. (2024). Development and validation of a one-step SMN assay for genetic testing in spinal muscular atrophy via MALDI-TOF MS. The Analyst. 150(1). 142–153. 1 indexed citations
4.
Li, Yanhong, Yuehong Chen, Yuanyuan Zhang, et al.. (2024). Euphorbia factor L2 alleviated gouty inflammation by specifically suppressing both the priming and activation of NLRP3 inflammasome. International Immunopharmacology. 138. 112598–112598. 3 indexed citations
5.
Pan, Bin, Yuanyuan Zhang, Zhigang Tang, et al.. (2024). Structure-activity relationships of natural and synthetic lathyrane-based diterpenoids for suppression of NLRP3-driven inflammation and gouty arthritis. Bioorganic Chemistry. 150. 107558–107558. 1 indexed citations
6.
Wu, Wenwen, Xing Ji, Xinyue Ma, et al.. (2023). Trends in innovative pediatric drug development in China based on clinical trial registration data. Frontiers in Medicine. 10. 1187547–1187547. 3 indexed citations
7.
Wu, Chen, Xing Ji, Kang Chen, et al.. (2023). SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53. Cancer Cell International. 23(1). 221–221. 8 indexed citations
8.
Lin, Fangyou, Cong Liu, Yuqi Xia, et al.. (2022). HO‐1 Contributes to Luteolin‐Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. Oxidative Medicine and Cellular Longevity. 2022(1). 3846217–3846217. 75 indexed citations
11.
Chen, Kang, Shaoming Zhu, Weimin Yu, et al.. (2022). Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer. Frontiers in Oncology. 12. 774307–774307. 6 indexed citations
12.
Fouda, Abdelrahman Y., Zhimin Xu, Jutamas Suwanpradid, et al.. (2022). Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair. Cell Death and Disease. 13(8). 745–745. 17 indexed citations
13.
Ji, Xing, Chen Wu, Kang Chen, et al.. (2022). TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers. 14(19). 4809–4809. 17 indexed citations
14.
Wu, Wenwen, Xing Ji, Hao Wang, et al.. (2021). Pediatric Clinical Trials in Mainland China Over the Past Decade (From 2009 to 2020). Frontiers in Medicine. 8. 745676–745676. 4 indexed citations
15.
Zeng, Yuanyuan, Feng Chen, Zhang Yong, & Xing Ji. (2021). Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis. World Journal of Pediatrics. 17(5). 476–483. 8 indexed citations
16.
Chen, Feng, et al.. (2021). Candida meningitis in an infant after abdominal surgery successfully treated with intrathecal and intravenous amphotericin B. Medicine. 100(37). e27205–e27205. 2 indexed citations
17.
Chen, Kang, Xing Ji, Weimin Yu, et al.. (2021). Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays. Frontiers in Oncology. 11. 782981–782981. 9 indexed citations
18.
Xu, Yan, Bing Xiao, Yu Liu, et al.. (2019). Identification of novel SMN1 subtle mutations using an allelic-specific RT-PCR. Neuromuscular Disorders. 30(3). 219–226. 9 indexed citations
19.
Jia, Yongjun, Xing Ji, Taiping He, et al.. (2018). Quantitative Analysis of Airway Tree in Low-dose Chest CT with a New Model-based Iterative Reconstruction Algorithm. Academic Radiology. 25(12). 1526–1532. 4 indexed citations
20.
Jiang, Wenting, Xing Ji, Yan Xu, et al.. (2013). Molecular Prenatal Diagnosis of Autosomal Recessive Spinal Muscular Atrophies Using Quantification Polymerase Chain Reaction. Genetic Testing and Molecular Biomarkers. 17(5). 438–442. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026